Home > RQB Financials

RavenQuest BioMed financials at a glance

Year	Year		2016	2017	2018	2019	2020	2014	2015	2021	2022	2024
Rev.	Revenue		0.00M	0.11M	1.26M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
GM %	Gross Margin %		0.00%	13.04%	63.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share		0.00	0.00	0.00
Div.	Dividends		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PR %	Payout Ratio %		0	0	0	0	0	0	0	0	0	0
Sha.	Shares		29m	29m	66.67m	114.12m	123.91m	0m	0m	182.13m	0m	0m
OCF	Operating Cash Flow		-0.03M	-2.50M	-11.10M	0.00M	0.00M	-0.04M	-0.02M	0.00M	0.00M	0.00M
FCF	Free Cash Flow		0.00M	0.00M	-23.36M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
FCFS	Free Cash Flow Per Share		-0.00	-0.08	-0.26	0.00	0.00	-0.00	-0.00	0.00	0.00	0.00

© Kit Invest S.L - StockForecast 2022. All rights reserved. Calle Alemania 3, 35100 San Bartolome de Tirajana, Spain | CIF: B57640591 Contact at [email protected]

StockForecast enables investors to make better investment decisions by providing financial data and objective market analysis. StockForecast has the objective information you need to analyze stocks and currencies. StockForecast is not a personal financial advisor and does not make recommendations or offers to buy or sell securities or currencies.